» Articles » PMID: 24046280

RNA Viruses and MicroRNAs: Challenging Discoveries for the 21st Century

Overview
Date 2013 Sep 19
PMID 24046280
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

RNA viruses represent the predominant cause of many clinically relevant viral diseases in humans. Among several evolutionary advantages acquired by RNA viruses, the ability to usurp host cellular machinery and evade antiviral immune responses is imperative. During the past decade, RNA interference mechanisms, especially microRNA (miRNA)-mediated regulation of cellular protein expression, have revolutionized our understanding of host-viral interactions. Although it is well established that several DNA viruses express miRNAs that play crucial roles in their pathogenesis, expression of miRNAs by RNA viruses remains controversial. However, modulation of the miRNA machinery by RNA viruses may confer multiple benefits for enhanced viral replication and survival in host cells. In this review, we discuss the current literature on RNA viruses that may encode miRNAs and the varied advantages of engineering RNA viruses to express miRNAs as potential vectors for gene therapy. In addition, we review how different families of RNA viruses can alter miRNA machinery for productive replication, evasion of antiviral immune responses, and prolonged survival. We underscore the need to further explore the complex interactions of RNA viruses with host miRNAs to augment our understanding of host-virus interplay.

Citing Articles

A Comparative Analysis of MicroRNA Expression in Mild, Moderate, and Severe COVID-19: Insights from Urine, Serum, and Nasopharyngeal Samples.

Soltane R, Almulla N, Alasiri A, Elashmawy N, Qumsani A, Alshehrei F Biomolecules. 2023; 13(12).

PMID: 38136554 PMC: 10742216. DOI: 10.3390/biom13121681.


miRNAs: The Key Regulator of COVID-19 Disease.

Hardin L, Xiao N Int J Cell Biol. 2022; 2022:1645366.

PMID: 36345541 PMC: 9637033. DOI: 10.1155/2022/1645366.


Attomolar sensitivity microRNA detection using real-time digital microarrays.

Ekiz Kanik F, Celebi I, Sevenler D, Tanriverdi K, Lortlar Unlu N, Freedman J Sci Rep. 2022; 12(1):16220.

PMID: 36171215 PMC: 9519543. DOI: 10.1038/s41598-022-19912-z.


The involvement of microRNAs in HCV and HIV infection.

Joshi N, Chandane Tak M, Mukherjee A Ther Adv Vaccines Immunother. 2022; 10:25151355221106104.

PMID: 35832725 PMC: 9272158. DOI: 10.1177/25151355221106104.


Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3.

Ullah A, Yu X, Odenthal M, Meemboor S, Ahmad B, Rehman I PLoS One. 2022; 17(5):e0268526.

PMID: 35617369 PMC: 9135289. DOI: 10.1371/journal.pone.0268526.


References
1.
Wang X, Ye L, Hou W, Zhou Y, Wang Y, Metzger D . Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood. 2008; 113(3):671-4. PMC: 2628373. DOI: 10.1182/blood-2008-09-175000. View

2.
Ylosmaki E, Lavilla-Alonso S, Jaamaa S, Vaha-Koskela M, Af Hallstrom T, Hemminki A . MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver. PLoS One. 2013; 8(1):e54506. PMC: 3551754. DOI: 10.1371/journal.pone.0054506. View

3.
Triboulet R, Mari B, Lin Y, Chable-Bessia C, Bennasser Y, Lebrigand K . Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007; 315(5818):1579-82. DOI: 10.1126/science.1136319. View

4.
Buggele W, Johnson K, Horvath C . Influenza A virus infection of human respiratory cells induces primary microRNA expression. J Biol Chem. 2012; 287(37):31027-40. PMC: 3438935. DOI: 10.1074/jbc.M112.387670. View

5.
Umbach J, Yen H, Poon L, Cullen B . Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells. mBio. 2010; 1(4). PMC: 2934610. DOI: 10.1128/mBio.00204-10. View